View in EDS

BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses.

Saved in:
Bibliographic Details
Title: BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses.
Authors: Rollin P; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Université Paris-Cité, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France., Pluskwa B; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Artru E; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Le Vaslot T; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Kartasheva-Ebertz D; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Biron D; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Bossis M; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Onodi F; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., LeMaoult J; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Rouas-Freiss N; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Chevalier MF; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.; Department of Medicine, University of California, San Diego, San Diego, CA, USA., Masson-Lecomte A; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Desgrandchamps F; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Xylinas E; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Université Paris-Cité, Paris, France., Tonnerre P; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.
Source: IScience [iScience] 2026 Jan 12; Vol. 29 (2), pp. 114676. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41660253
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4<superscript>+</superscript> Th1 responses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rollin+P%22">Rollin P</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Université Paris-Cité, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pluskwa+B%22">Pluskwa B</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Artru+E%22">Artru E</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Le+Vaslot+T%22">Le Vaslot T</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kartasheva-Ebertz+D%22">Kartasheva-Ebertz D</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Biron+D%22">Biron D</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bossis+M%22">Bossis M</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Onodi+F%22">Onodi F</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22LeMaoult+J%22">LeMaoult J</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rouas-Freiss+N%22">Rouas-Freiss N</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chevalier+MF%22">Chevalier MF</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lindestam+Arlehamn+CS%22">Lindestam Arlehamn CS</searchLink>; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Sette+A%22">Sette A</searchLink>; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.; Department of Medicine, University of California, San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Masson-Lecomte+A%22">Masson-Lecomte A</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Desgrandchamps+F%22">Desgrandchamps F</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Xylinas+E%22">Xylinas E</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Université Paris-Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tonnerre+P%22">Tonnerre P</searchLink>; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2026 Jan 12; Vol. 29 (2), pp. 114676. <i>Date of Electronic Publication: </i>2026 Jan 12 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41660253
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.isci.2026.114676
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 114676
    Titles:
      – TitleFull: BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rollin P
      – PersonEntity:
          Name:
            NameFull: Pluskwa B
      – PersonEntity:
          Name:
            NameFull: Artru E
      – PersonEntity:
          Name:
            NameFull: Le Vaslot T
      – PersonEntity:
          Name:
            NameFull: Kartasheva-Ebertz D
      – PersonEntity:
          Name:
            NameFull: Biron D
      – PersonEntity:
          Name:
            NameFull: Bossis M
      – PersonEntity:
          Name:
            NameFull: Onodi F
      – PersonEntity:
          Name:
            NameFull: LeMaoult J
      – PersonEntity:
          Name:
            NameFull: Rouas-Freiss N
      – PersonEntity:
          Name:
            NameFull: Chevalier MF
      – PersonEntity:
          Name:
            NameFull: Lindestam Arlehamn CS
      – PersonEntity:
          Name:
            NameFull: Sette A
      – PersonEntity:
          Name:
            NameFull: Masson-Lecomte A
      – PersonEntity:
          Name:
            NameFull: Desgrandchamps F
      – PersonEntity:
          Name:
            NameFull: Xylinas E
      – PersonEntity:
          Name:
            NameFull: Tonnerre P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 01
              Text: 2026 Jan 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2589-0042
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: IScience
              Type: main
ResultId 1